These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 1681762)

  • 41. Edrophonium and neostigmine for reversal of the neuromuscular blocking effect of vecuronium.
    Engbaek J; Ording H; Ostergaard D; Viby-Mogensen J
    Acta Anaesthesiol Scand; 1985 Jul; 29(5):544-6. PubMed ID: 2863917
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antagonism of rapacuronium using edrophonium or neostigmine: pharmacodynamics and pharmacokinetics.
    Mills KG; Wright PM; Pollard BJ; Scott JM; Hing JP; Danjoux G; Hunter JM
    Br J Anaesth; 1999 Nov; 83(5):727-33. PubMed ID: 10690134
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reversal of profound paralysis: use of large doses of edrophonium to antagonize vecuronium and pancuronium induced neuromuscular blockade.
    Power SJ; Jones RM
    Acta Anaesthesiol Scand; 1989 Aug; 33(6):478-81. PubMed ID: 2572135
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Priming with anti-cholinesterases--the effect of different priming doses of edrophonium.
    Naguib M; Abdulatif M
    Can J Anaesth; 1988 Jan; 35(1):53-7. PubMed ID: 3349555
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sevoflurane and isoflurane impair edrophonium reversal of vecuronium-induced neuromuscular block.
    Morita T; Kurosaki D; Tsukagoshi H; Sugaya T; Saito S; Sato H; Fujita T
    Can J Anaesth; 1996 Aug; 43(8):799-805. PubMed ID: 8840059
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Edrophonium antagonism of cisatracurium-induced neuromuscular block: dose requirements in children and adults.
    Abdulatif M; El-Sanabary M
    Anaesth Intensive Care; 2001 Aug; 29(4):364-70. PubMed ID: 11512646
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neostigmine and edrophonium for reversal of pipecuronium neuromuscular blockade.
    Abdulatif M; Naguib M
    Can J Anaesth; 1991 Mar; 38(2):159-63. PubMed ID: 1850665
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reversal of intense neuromuscular blockade following infusion of atracurium.
    Engbaek J; Ostergaard D; Skovgaard LT; Viby-Mogensen J
    Anesthesiology; 1990 May; 72(5):803-6. PubMed ID: 2160206
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Edrophonium for the antagonism of neuromuscular blockade in dogs.
    Clutton RE
    Vet Rec; 1994 Jun; 134(26):674-8. PubMed ID: 7941276
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antagonism of blockade produced by atracurium or vecuronium with low doses of neostigmine.
    Jones JE; Parker CJ; Hunter JM
    Br J Anaesth; 1988 Nov; 61(5):560-4. PubMed ID: 2905146
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of tactile and mechanomyographical assessment of response to double burst and train-of-four stimulation during moderate and profound neuromuscular blockade.
    Kirkegaard-Nielsen H; Helbo-Hansen HS; Severinsen IK; Lindholm P; Pedersen HS; Schmidt MB
    Can J Anaesth; 1995 Jan; 42(1):21-7. PubMed ID: 7889580
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The ulinastatin-induced effect on neuromuscular block caused by vecuronium.
    Saitoh Y; Fujii Y; Oshima T
    Anesth Analg; 1999 Dec; 89(6):1565-9. PubMed ID: 10589650
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of neostigmine or edrophonium on force of contraction when administered at a train-of-four ratio of 0.9 in anesthetized dogs.
    Romano M; Martin-Flores M; Sakai DM; Tseng CT; Campoy L; Gleed RD
    Vet Anaesth Analg; 2017 Nov; 44(6):1313-1320. PubMed ID: 29066245
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Optimum time for neostigmine reversal of atracurium-induced neuromuscular blockade.
    Kirkegaard-Nielsen H; Helbo-Hansen HS; Lindholm P; Severinsen IK; Pedersen HS; Jensen EW
    Can J Anaesth; 1996 Sep; 43(9):932-8. PubMed ID: 8874911
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reversal of atracurium-induced neuromuscular block in paediatric patients.
    Kirkegaard-Nielsen H; Meretoja OA; Wirtavuori K
    Acta Anaesthesiol Scand; 1995 Oct; 39(7):906-11. PubMed ID: 8848890
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between single twitch depression and train-of-four fade: influence of relaxant dose during onset and spontaneous offset of neuromuscular blockade.
    Power SJ; Jones RM
    Anesth Analg; 1987 Jul; 66(7):633-6. PubMed ID: 2886077
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Priming with anti-cholinesterases--the effect of different combinations of anti-cholinesterases and different priming intervals.
    Naguib M; Abdulatif M
    Can J Anaesth; 1988 Jan; 35(1):47-52. PubMed ID: 3349554
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is recovery of neuromuscular transmission complete after the use of neostigmine to antagonize block produced by rocuronium, vecuronium, atracurium and pancuronium?
    Baurain MJ; Hoton F; D'Hollander AA; Cantraine FR
    Br J Anaesth; 1996 Oct; 77(4):496-9. PubMed ID: 8942335
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dose-response relationships for edrophonium and neostigmine antagonism of pipecuronium-induced neuromuscular block.
    Naguib M; Abdulatif M
    Anesth Analg; 1994 Feb; 78(2):306-11. PubMed ID: 8311284
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of the train-of-four fade profiles produced by vecuronium and atracurium.
    Fletcher JE; Sebel PS; Mick SA; Van Duys J; Ryan K
    Br J Anaesth; 1992 Feb; 68(2):207-8. PubMed ID: 1347231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.